A new method for high throughput screening has been developed based upon the inclusion of the target receptor, chaperon protein, nuclear receptors and mitochondrial receptors in a flowing chromatographic system. In this approach, the target protein is immobilized on a solid support and the support packed into a small column. The test chemicals are passed through the column, over the immobilized target, and the time that it takes for the compounds to pass from the beginning of the column to its end is directly related to the strength of interaction between the target and the compound, i.e. the binding affinity of the ligand-receptor complex. Using this method, complex chemical and biological mixtures can be rapidly sorted between compounds that interact and do not interact with the disease-related target. At the same time, the compounds that bind to the target are themselves rapidly sorted between low, medium and high affinity binders. Thus, the method quickly provides a large amount of data with high information content. We have developed columns containing G-protein coupled receptors (GPCR) including the kappa, mu and delta subtypes of the opioid recpetor, beta2-adrenergic receptors, various subtypes of the nicotinic receptor and columns containing multiple GPCRs including a histamine-1 and P2Y1 receptor column and a multiple ligand-gated ion channel column containing the alpha 7 and alphaXbetaY nicotinic acetylcholine receptors, NMDA and GABA(A)receptors. The nicotinic receptor-based columns have been used to screen tobacco smoke condensates and initial results indicate that previously unknown compounds have been identified. These compounds are being assessed for their pharmacological activity as competitive agonists and antagonists and non-competitive inhibitors. A study using non-competitive inhibitors and non-linear chromatography was conducted and demonstrated that the method can be used to identify and characterize the non-competitive inhibitors which bind in the central lumen of the receptor as well as at an extra-receptor site identified as the quinacrine binding site. Chemometric analysis was used to develop quantitative structure-activity relationships (QSAR) and the resulting equations can be used to predict the pharmacological activity of a compound. Molecular modeling studies were used to describe and predict the interactions between the nicotinic receptors and non-competitive inhibitors. The computer-based studies have been used as the basis for a patent application entitled Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors (ref number: E-158-2003/0-US-01). The general approach has been expanded through the immobilization of heat shock 90 (Hsp90) protein in the surface of magnetic beads. The Hsp90-beads were used to extract small molecules that bind to Hsp90 from chemical and botanical mixtures and to extract proteins that form complexes with Hsp90 from protein mixtures. The beads were also used to extract proteins that bind to Hsp90 from cellular extracts and indicate that the approach can be used to study intra-cellular protein-protein interactions and to identify new pathways associated with Hsp90. We have recently demonstrated that astrocytoma and glioblastoma call lines express the ERRa and ERRg and that these nuclear receptors are key targets in the treatment of brain cancer. The LC-ERRa and LC-ERRg columns were created and characterized and will be used to screen chemical mixtures and biological matrices for new lead drug candidates.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAAG000295-12
Application #
8736513
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
2013
Total Cost
$776,063
Indirect Cost
Name
National Institute on Aging
Department
Type
DUNS #
City
State
Country
Zip Code
Ravichandran, S; Singh, N; Donnelly, D et al. (2014) Pharmacophore model of the quercetin binding site of the SIRT6 protein. J Mol Graph Model 49:38-46
Habicht, K-L; Singh, N S; Khadeer, M A et al. (2014) Characterization of a multiple endogenously expressed adenosine triphosphate-binding cassette transporters using nuclear and cellular membrane affinity chromatography columns. J Chromatogr A 1339:80-5
Singh, N S; Habicht, K-L; Dossou, K S S et al. (2014) Multiple protein stationary phases: a review. J Chromatogr B Analyt Technol Biomed Life Sci 968:64-8
Singh, N; Ravichandran, S; Spelman, K et al. (2014) The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads. J Chromatogr B Analyt Technol Biomed Life Sci 968:105-11
Calleri, Enrica; Pochetti, Giorgio; Dossou, Katina S S et al. (2014) Resveratrol and its metabolites bind to PPARs. Chembiochem 15:1154-60
Bartolini, Manuela; Wainer, Irving W; Bertucci, Carlo et al. (2013) The rapid and direct determination of ATPase activity by ion exchange chromatography and the application to the activity of heat shock protein-90. J Pharm Biomed Anal 73:77-81
Habicht, K-L; Frazier, C; Singh, N et al. (2013) The synthesis and characterization of a nuclear membrane affinity chromatography column for the study of human breast cancer resistant protein (BCRP) using nuclear membranes obtained from the LN-229 cells. J Pharm Biomed Anal 72:159-62
Moaddel, Ruin; Musyimi, Harrison K; Sanghvi, Mitesh et al. (2010) Synthesis and characterization of a cellular membrane affinity chromatography column containing histamine 1 and P2Y(1) receptors: a multiple G-protein coupled receptor column. J Pharm Biomed Anal 52:416-9
Arias, Hugo R; Gumilar, Fernanda; Rosenberg, Avraham et al. (2009) Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Biochemistry 48:4506-18
Woo, Anthony Yiu-Ho; Wang, Tian-Bing; Zeng, Xiaokun et al. (2009) Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol 75:158-65

Showing the most recent 10 out of 19 publications